Strata Critical Medical Schedules Fourth Quarter 2025 Earnings Conference Call
Strata Critical Medical (Nasdaq: SRTA) will release fourth-quarter 2025 financial results on March 3, 2026 before the market opens and will host a conference call at 8:00 am Eastern Time the same day.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Strata Critical Medical (Nasdaq: SRTA) will release fourth-quarter 2025 financial results on March 3, 2026 before the market opens and will host a conference call at 8:00 am Eastern Time the same day.
The call will be hosted by Will Heyburn (Co-CEO and CFO) and Melissa Tomkiel (Co-CEO and General Counsel), include a Q&A session, and require registration to receive dial-in details and a unique PIN. An audio-only webcast will be available on the company investor relations site and a replay will remain available for one year.
Details
News Market Reaction – SRTA
On Feb 11, the first trading day after this news, SRTA closed 2.20% below the previous close.
Data tracked by StockTitan Argus for the Feb 11 session.
Key Figures
- Q3 2025 revenue
- $49.3M
- From Q3 2025 earnings release
- Q3 2025 revenue growth
- 36.7% YoY
- From Q3 2025 earnings release
- Q3 2025 gross margin
- 19.4%
- From Q3 2025 earnings release
- Q3 2025 net loss
- $(9.7)M
- From Q3 2025 earnings release
- 2025 revenue guidance
- $185–195M
- Raised in Q3 2025 earnings release
- 2026 revenue target
- $255–270M
- Provided at 2025 Investor Day
- 2026 Adjusted EBITDA
- $28–32M
- Provided at 2025 Investor Day
- ABL facility size
- $30.0M (up to $50.0M with accordion)
- Revolving credit agreement with JPMorgan Chase
Previous Conferences,earnings Reports
-
Announced Q3 2025 earnings release timing and conference call details.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
NEW YORK, Feb. 10, 2026 (GLOBE NEWSWIRE) -- Strata Critical Medical (Nasdaq: SRTA, “Strata” or the “Company”), will release financial results for the fourth quarter ended December 31, 2025 on Tuesday, March 3, 2026 before the market opens. The company will hold a conference call on the same day at 8:00 am Eastern Time to discuss the results. The call will be hosted by Will Heyburn, Strata’s Co-Chief Executive Officer and Chief Financial Officer, and Melissa Tomkiel, Strata’s Co-Chief Executive Officer and General Counsel, and will include a question-and-answer session for call participants.
To join the live call, please register here. Upon registration, a dial-in and unique PIN will be provided to join the call.
An audio-only webcast of the call may be accessed from the Investors section of the Company’s website at https://ir.stratacritical.com/ or by registering at the link here. A replay of the webcast will be available for one year.
About Strata Critical Medical, Inc.
Strata is a time-critical logistics and medical services provider to the U.S. healthcare industry. We operate one of the nation’s largest air transport and surgical services networks for transplant hospitals and organ procurement organizations, offering an integrated “one call” solution for donor organ recovery.
Strata’s core services include air and ground logistics, surgical organ recovery, organ placement and normothermic regional perfusion for the transplant industry, as well as perfusion staffing and equipment solutions for cardiovascular surgery centers, offered under the Trinity Medical Solutions and Keystone Perfusion brands.
For more information, visit https://stratacritical.com/.
Contacts
Mathew Schneider
investors@srta.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.